Kestrel

NEYPPC Pharmacy - Unlicensed Imported Medicines (Wave 1)

Leeds Teaching Hospitals NHS Trust · published Wed 23 Sep 2026

In plain English

Reading the notice and writing a summary. This takes a few seconds the first time.

Who holds it now

Last won by Clinigen Healthcare Limited and Mawdsley-Brooks & Co Ltd and Durbin PLC and 4 more in Mar 2026, for £27.4m.

What you're up against

  • The same firms have won it the last 2 times Kestrel found: expect them to bid again, and to know the work well.
  • 8 different firms won this buyer's 2 awards for this kind of work in 2026.
  • It last went for £27.4m in 2026.
  • The last award named 7 suppliers: it may be a framework, where many firms are chosen.

From Leeds Teaching Hospitals NHS Trust's earlier award notices for the same kind of work. The tender documents usually say which contract this one replaces.

The notice doesn't say where the documents are, but Leeds Teaching Hospitals NHS Trust's other tenders use health-family.force.com. Register there (it's free) and look for this tender, or email the buyer's contact on the notice.

The notice as published

The North East and Yorkshire NHS Pharmaceutical Purchasing Consortium intends to run a further competition under its established Dynamic Market for the supply of Unlicensed Imported Medicines. This route enables flexible, efficient and sustainable sourcing by drawing on a continuously open pool of qualified suppliers. The requirement will cover the provision of unlicensed medicines imported from trusted countries and must fully comply with all applicable UK regulatory standards. Participating suppliers will be required to hold the appropriate import and wholesale licenses, together with all other permissions necessary to supply unlicensed medicines within the UK. Using the established Dynamic Market ensures that NHS Trusts across the region can access safe, compliant, and competitively sourced unlicensed medicines, supporting resilient supply chains and maintaining strong assurance of product quality.